chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician referring to a patient of unknown age and gender. Information about concurrent conditions and medical history were not provided. On an unknown date the patient was vaccinated with the first dose of GARDASIL (lot#, dose and route not reported). No information regarding concomitant therapy was provided. The reporter stated that the patient fainted at an unspecified time after "jumping up from the table" after receiving their first dose of GARDASIL. The physician reported that the patient went to an unspecified emergency room at an unspecified time after fainting. The patient did not receive two more doses of GARDASIL on unspecified dates and did not develop any reactions to those two doses. The outcome of the event was unknown. Additional information is not expected as there was no consent for follow up contact.
Zostavax 0.65 mg SC given on 4/4/08.  24 hours later, painful red rash and vesicles on R face, scalp and eye consistent with zoster ophthalmicus. In other words, he developed shingles one day after shingles vaccine given.  No contraindications for vaccine.
High pitched screaming, inconsolably, pain. Started at ~ 230 pm, continuously until end of visit ~ 415pm.
This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPNEA (developed shortness of breath) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Type 2 diabetes mellitus, Congestive heart failure, Hypertension, Rheumatoid arthritis, Atrial fibrillation and Pacemaker insertion (cardiac). Concurrent medical conditions included Drug allergy (Cortisone). On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DYSPNEA (developed shortness of breath). The patient was treated with OXYGEN for Shortness of breath, at a dose of UNK dosage form and SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for Shortness of breath, at a dose of UNK dosage form. At the time of the report, DYSPNOEA (developed shortness of breath) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Vital signs measurement: stable (normal) stable. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Concomitant medication was not reported. The patient continued with shortness of breath even with home oxygen and albuterol inhaler.  It was reported that no epinephrine or Benadryl was administered. Emergency Medical Services was called and evaluated the patient's condition; vitals were stable, so did not transport to ER. This case was linked to MOD-2021-028961, MOD-2021-032365.
worsening of eczema; This spontaneous case was reported by an other health care professional and describes the occurrence of ECZEMA (worsening of eczema) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.    Co-suspect product included non-company product DUPILUMAB (DUPIXENT) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and DUPILUMAB (DUPIXENT) (unknown route) 1 dosage form. On an unknown date, the patient experienced ECZEMA (worsening of eczema). At the time of the report, ECZEMA (worsening of eczema) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication was provided by the Reporter. No Treatment Information was provided by the Reporter.
expired Bexsero dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received Men B NVS (Bexsero) (batch number 7HH92, expiry date 28-FEB-2023) for prophylaxis.   On 16-MAR-2023, the patient received Bexsero. On 16-MAR-2023, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: expired Bexsero dose administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 21 Mar 2023 The Nurse reported a medical assistant administered an expired vaccine of Bexsero. The Vaccine Administration Facility was the same as Primary Reporter.  The reporter consented to follow up via email. The patient received expired vaccine of Bexsero which led to expired vaccine used.
Mother brought child to office this morning stating child woke up not feeling well. Elevated temp noted on triage of 102.7. Strep negative, Rapid Flu negative. Sister ill also with low grade temp. Fever up to 103.6 after Motrin but down to 102.1 after additional Tylenol tx.
Ongoing symptoms since 48 hours from dose #2 include:  shortness of breath, even while seated; tightness in chest when taking a deep breath; decreased blood oxygen (93-95% while still, 91% while walking short distance); increased pulse rate (80-91 while sitting, escalating to 118 when walking); occasional dizzyness
Patient experienced numbness on the side of her body where she received the shot; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), outcome "recovered", described as "Patient experienced numbness on the side of her body where she received the shot". It was unknown if therapeutic measures were taken as a result of hypoaesthesia.  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.
Developed Dermatographia 11 days after receiving  Moderna booster.   No history of this or any allergies/autoimmune issues prior to this.
Case number PHEH2012US015607 is an initial spontaneous report received from a nurse on 03 Aug 2012 with a follow-up received on 05 Sep 2012: This report refers to a 12-years-old female. Her current condition included exercise induced asthma. It was reported that she received intramuscularly 0.5 ml MenCWY liquid conjugate component of MENVEO (batch number: M11051) inadvertently reconstituted with another MenCWY vial instead of Men A lyophilized component on 03 Aug 2012. She was concomitantly also vaccinated with a booster dose of TDaP (other manufacturer, batch number: C41181AA) intramuscularly in to the left deltoid on 03 Aug 2012. No adverse reaction was reported following the maladministration. Follow-up received from the nurse on 05 Sep 2012: Updated current condition and concomitant vaccination.
HYPOTENSION 10/25/2022 COVID-19 ACUTE BRONCHITIS
PT GOT THE VACCINE ELSEWHERE: PT ALSO STATES, THIS IS HIS 2ND DOSE OF pziefer HE STATES HE HAD PAIN ON BOTH LEGS AFTER A COUPLE OF HOURS OF THE VACCINE TODAY HE COMES IN WITH BOTH FEET SWOLLEN AND PAIN
Red spots started showing up, mainly on my back; Diagnosed with Shingles (Herpes Zoster) / confirmed my diagnosis; Feeling a burning sensation on my back and right side of my chest; Severe pain / some strong pain; today's blister stage; This case was reported by a consumer and described the occurrence of shingles in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th January 2021, the patient received Shingrix. In January 2021, less than a week after receiving Shingrix, the patient experienced pain and blister. On 20th January 2021, the patient experienced shingles and burning sensation. On 22nd January 2021, the patient experienced red spotty rash. The patient was treated with valaciclovir hydrochloride (Valacyclovir) and gabapentin (Neurontin (Gabapentin)). On an unknown date, the outcome of the shingles, burning sensation, red spotty rash, pain and blister were not recovered/not resolved.   It was unknown if the reporter considered the shingles, burning sensation, red spotty rash, pain and blister to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient himself. Two days after receiving Shingrix, the patient started feeling a burning sensation on his back and right side of his chest. The patient stated that 4 days after receiving Shingrix, the burning sensation had increased, and red spots started showing up, mainly on his back. On 22nd January 2021, in the morning, he got a response from his primary care physician and he was able to go to an appointment, where they confirmed his diagnosis of Herpes zoster without complication  and had BMI (body mass index) 36.0 to 36.9 and because the patient was in severe pain, he was prescribed with Neurontin (Gabapentin) (Drug Code 69097-0813-12) 100 mg (quantity 30) to take at bedtime and was advised to return in about 6 week for annual (next visit, around 5th March 2021) and was discussed to exercise 3x per week (30 min per time). On 22nd January 2021, blood pressure measurement result was 133/88 mm hg, body mass index result was 36.68, body temperature result was 98.1 degree F, heart rate result was 101 /min, oxygen saturation result was 96 percent and respiratory rate result was 18 /min. On 23rd January,2021, the patient's symptoms increased and in the early morning, the patient went and was diagnosed with Shingles (Herpes Zoster) and was prescribed with Valacyclovir (Drug Code 59746-0325-37) 1 gm tablets (quantity 21) to take 3 times a day for 7 days. The patient had provided the picture of reporting day blister stage. The patient stated that the results of receiving the vaccination had been a huge source of worry and had taken a significant toll in his life and he would like to know what steps we were able to take to make things right in this difficult situation.
Admitted to hospital on 1/23/22 for Lower extremity weakness, discharge planned for 1/27/22 to skilled nursing facility which required COVID test prior to discharge. pt tested COVID+ on 1/27/22, asymptomatic
This spontaneous report as received from a other health professional (Nurse) refers to a 5 year old female patient. On 22-JUN-2017 the patient was vaccinated with VARIVAX, subcutaneously for prophylaxis. (Lot # M045205, expiration date 11-NOV-2017). On the same day after onset of therapy the patient experienced injection site erythema and blister. The outcome of injection site erythema and blister was unknown. Additional information has been requested.
Pt recv vax on 11/2/98; on same day pt exp nausea, hot feeling; tx=Pepto Bismol
Narrative: Pt received an expired Pfizer COVID-19 vaccine on 4/6/22. The expiration time of the vaccine is undetermined as the healthcare worker could not see the date/time on the syringe as it was already in the sharps container, but knows for certain it was a vaccine not prepared on 4/6/22.
Moderate axillary lymphadenopathy, moderate-severe edema & erythema at injection site to entire upper arm, myalgias, diaphoresis and fever ranging between 101-103.7 10/22-10/25.
Arm soreness and pain two hours after injection. Fatigue and sleepiness. Arm pain at injection site during first night. This happened during the first and second dose.
I had my vaccination on 09/17/2022. I started to have a scratchy throat on 02/16/2023. On 02/17/2023 I had muscle and joint aches with a fever and headache. I tested COVID-19 Positive on 02/17/2023. I was on vacation in which the doctor prescribed a antibiotic but I chose not to take it because I had been on an antibiotic the week prior for diverticulitis. I still have a lingering dry cough and swollen lymph node on the right side of my neck on 03/27/2023.
Shortness of Breath, Hard to breathe, wheezing Had to be put on Oxygen daily after the event.
Within 24 hours of the initial Pfizer Vaccine, extreme tinnitus in both ears.   Within 48 hours, internal shaking began..   The tinnitus calmed down after about 30 days after the vaccine.  The Internal Shaking continues and there has been no improvement after 6 months.
pt recv vax in 1995 & APR97 pt devel chickenpox w/ 30-40 lesions & was treated w/Acyclovir;
Mom of pt stated that within a few hours of administration, child c/o pain on site of injection, redness, itching, headache and mild fever.  The next day, swelling spread down child arm, itching and redness continued, other symptoms became mild.
Approximately 15-20 mins after vaccination, the pt developed "welts" that started on feet and move up to torso. welts stopped at torso. No difficulty breathing or any other symptoms. Follow-up phone call two hours later states that welts were fading. Pt took Benadryl and Alegra at onset of welts. Pt has history of hives before where he was hospitalized. Had allergy test with negative results. No hives x 3 weeks before Hep A/B shots.
My last period was Jan 7, 2021. Received Vaccine, dose 2 on 1/25/21 (I did not know I was pregnant at that time). Had a miscarriage and lost baby Feb 18-21
Received the first dose on 09JUN2021; This case was received via Regulatory Authority (Reference number: US-irms-MOD21-144332) on 16-Sep-2021 and was forwarded to Moderna on 16-Sep-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the first dose on 09JUN2021) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the first dose on 09JUN2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the first dose on 09JUN2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not reported.  Treatment medications was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Sep-2021: Follow up received confirms that patient did not experienced any adverse events so the case is invalid.
Pt recvd a series of 3 Engerix-B doses given 6NOV89, 12DEC89, & 2MAY90 subsequently tested for HBSAB & found not to have converted;
Shortness  of breath, chest heaviness immediately after receiving vaccine  Dx with bronchospasm
The patient had a temperature of 103. 9 days after vaccine was given. Reportedly a rash on her trunk area.
Painful right-side swelling of lymph nodes a few days after booster. Tender, palpable lymph nodes under the right arm-pit. It continued through the month of January. Saw Physician who said it was consistent with reactive lymphadenopathy due to prior COVID vaccination. They did ultrasound, and said it was consistent with vaccine response. it was palpable ( I can feel them with my hand), and it continues to this day.
I was a breastfeeding mother at the time of the vaccine. About three days after my first vaccine, my milk supply went down. After my second vaccine my milk supply was pretty much nothing. I did choose not to nurse for the first three days after having my vaccines on both occasions. During those three days I did pump and freeze the milk. After those first three days from getting the vaccine I did resume breastfeeding as normal.
itching began sat PM, 10PM called ER instructed to give DPH & calamine lotion;4DEC throwing up @ school;in AM low grade temp;
On 12/5/01, the pt's right arm reddened. On 12/6/01, the entire upper arm was swollen, skin taut and reddened. He was taken to ER and given Keflex and Benadryl. On 12/7/01, the swelling was extended past his elbow. He denies pain. Child is active.
arm pain (felt sore); felt groggy; felt super tired; A spontaneous report was received from a Consumer concerning a 38-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm pain (felt sore), felt groggy, felt super tired.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Feb 2021, the patient experienced the events arm pain (felt sore). felt groggy, felt super tired.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  On an unknown date the outcome of events, arm pain (felt sore), On an unknown date the outcome of events, felt groggy, On an unknown date the outcome of events, felt super tired was not reported.
Admitted on the 22nd for back pain and ascending paraalysis in right arm.  No respiratory difficulties. Still inpatient physical therapy.
Headache, sinus pressure, cough, muscle aches, joint aches, pain throughout body, sore throat, chest discomfort, fatigue,
It has been almost a year, and my arm is still so painful that I am unable to really use it.  This cannot be normal.
Received DPT vaccine on 6-4-07 during routine physical. Shortly thereafter began experiencing excruciatingly painful muscle and joint pain in all extremities and back as well as losing strength in arms hands and legs. Most intense pain was in upper arms and thighs. Lost all strength in hands and arms and went to urgent care on 6-25-07; given script for pain referred to my primary MD. Have been confined to bed since then.
Started having bleeding, soreness, and pain in her gums that would run up to her head and she would have headaches after the 1st vaccine. Nostrils were all red on this inside. Runs fever at night. Little dizzy and nauseated. Had first Pfizer vaccine March 10th and the 2nd March 28th. Symptoms flared up again after the 2nd vaccine and have since started to improve. After she went to the dentist, everything seems to be okay and is resolving.
Feels hot; Fevers/Her temperature is currently 102 degrees; Shakes; Vomiting; Diarrhea; This is a spontaneous report from a contactable consumer reported for self. This 49-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0142) via unspecified route of administration on 12Jan2021 at single dose in left arm for COVID-19 immunization. The patient worked front line in the emergency room (ER). The patient medical history included stage 4 metastatic melanoma from 2013. The patient concomitant medications included nivolumab (OPDIVO) for stage 4 metastatic melanoma. The patient previously received first dose of BNT162B2 (Lot: EJ1685) on 22Dec2020 at single dose for COVID-19 immunization and she didn't feel anything with that dose. The patient experienced shakes, fever, diarrhea, vomiting on 13Jan2021. The patient reported that she had been having shakes and fevers that started at 2:00 AM this morning 13Jan2021. Her temperature is currently 102 degrees on 13Jan2021. It was better but she let herself go 5-6 hours without taking anything. She had been alternating paracetamol (TYLENOL) and ibuprofen (MOTRIN). When it wore off she instantly felt hot and shaky. She also had started having diarrhea and vomiting. The outcome of the events was unknown.
PAITENT WAS GIVEN VACCINE AT APPROX 430PM AND WAS SITTING IN CHARIS FOR OBSERVATION. AROUND 435 PATIENT PASSED OUT OF CHAIR FACE FIRST ON TO FLOOR. PHARMACIST ATTENDED TO APTIENT WHO WAS UNREPONSIVE. 911 WAS CALLED. PATIENT WAS WEARING MASK AND WAS REMOVED TO HELP AIR FLOW. PATIEN STARTED TO COME TO AND WAS LIGHT HEADED. SHE WAS GIVEN WATER AND DID SIT UP. PAITENT HAD BLPOOD IN MOUTH FROM FALLIGN BUT NO EXTERNAL INJURY. EMS ARRIVED AND CLEARED PATIENT TO LEAVE. HUSBAND DID COME TO DRIVE PATIENT HOME. WAS GIVEN WATER AND ICE FOR INJURY TO INSIDE MOUTH.
This non-serious spontaneous case, was initially received on 09-Oct-2017, reported by other non-health professional and concerns a 32-year-old, adult pregnant female patient. Patient's medical history was not reported. The patient's concomitant medication included vitamins. The subject's last menstrual period date was on 15-Sep-2017. There was no evidence of defect or adverse findings from prenatal test. No spontaneous abortion was reported and had no family history (offspring, maternal and paternal) of congenital malformation and no medications were taken by the father prior to conception. On 09-Oct-2017, the patient received FLUCELVAX QIV (dose: 0.5ml, route of administration: intramuscular, batch number: 195243, expiry date: 30-Jun-2018, anatomical location: deltoid). On 09-Oct-2017, the patient received vaccine at three weeks of pregnancy. It was reported that, there was no adverse reactions experienced by fetus. The estimated date of delivery was on 20-Jun-2018. The outcome of the event was not reported. Non-significant case correction received 09-Oct-2017: Batch number (195243) was added on the screen and updated expiry date. The narrative was amended accordingly.
Shortly after being injected with the vaccine, my hearing began to go in and out in both ears. It created a sensation of water filling in your ear while in shower then letting it drain out. I have service-connected tinnitus but this is worse. I am unable to hear as good as I did and it has started to affect my performance at work
Pain and swelling in my axillary area. It persisted for 3-4 days making it very uncomfortable and painful to use my left arm.
After 3rd dose, later in the day started feeling aching on left side of chest/shoulder. This quickly moved directly around heart area and included sharp pain around heart. Heart felt very tight and was aching. Kept getting worse throughout week. Left arm went numb 6 days after vaccine. Went to ER on day 6 once arm numbness started. They took EKG, blood work and xray. Found nothing immediately wrong. Gave anti-inflammatory shot and 5 day anti-inflammatory prescription. A few days after prescription ended chest pain kicked up again, being very tight and painful at times. Would take ibuprofen to help pain. Started taking quercetin, vitamin c and zinc daily which seems to b helping. A month later has gotten better but still aches and feels like a cramp around heart from time to time.
client vaccinated with pfizer covid 19 vaccine that was not reconstituted. Error was caught, and PHSC aware.
No initial reaction to the vaccine, but I started to get what I thought to be a sinus infection about two days after the first vaccine. Congested, but overall healthy (ran 13 miles on 04/04/2021). I woke up in the night about a week after the first vaccine (around 4:00 AM on 04/07/2021) having trouble breathing -- tight throat and chest. I thought it was my sinus infection, received a negative covid test, and started taking augmentin. The tightness continued for about 3 days along with a shortness of breath, no other symptoms though. My resting heart rate was also hovering around 100 bpm until the weekend before the second vaccine.  I had no initial reaction to the second vaccine either. However, about a week later the same thing happened. I woke up around 1:00 AM 04/26/2021 hyperventilating with a tight throat and chest. This continued for about 3 days again, so I took another covid test -- negative again. My resting heart rate was back up to 100 bpm. I started to think it was a strange reaction to the vaccine, so I still had my infusion for Crohn's Disease on 04/30/2021. Blood pressure was okay, somewhere around 104/67 I think, but my heart rate was 107 bpm. After that weekend, I felt back to normal. Not sure if this was all caused by the vaccines, but it seems possible.